Agilent Technologies Inc. (NYSE: A) today announced that Dr.
Carolyn Mountford has received an Agilent Thought Leader Award in
recognition of her innovative work using nuclear magnetic resonance
(NMR) spectroscopy technology in cancer research.
Dr. Mountford is a professor of radiology at The
University of Newcastle Australia School of Health Sciences, and
Harvard Medical School. She is the director of Newcastle’s
Magnetic Resonance Centre for Clinical Research and director of the
Center for Clinical Spectroscopy at the Brigham and Women’s Hospital in
Boston.
The award will support Dr. Mountford and her team at the University of
Newcastle in their pioneering research on novel in vivo NMR techniques
that may help identify breast cancer in high-risk women. Preliminary
data suggest that NMR may detect early changes in breast tissue that
reflect rapid tumor growth. Moreover, NMR may be used to analyze primary
breast tumors to determine if the cancer cells have spread to the lymph
nodes, preventing unnecessary surgery.
“NMR spectroscopy is a highly accurate and precise tool for analyzing
human tissue,” said Dr. Mountford. “This technology could help
pathologists diagnose breast cancer more quickly and accurately, enable
surgeons to make more informed decisions and, ultimately, improve the
quality of cancer care for patients.”
“Agilent is committed to facilitating solutions for personalized
medicine, and we are excited to support Dr. Carolyn Mountford and her
team in their quest to develop NMR-based screening techniques,” said
Regina Schuck, Ph.D., vice president and general manager of Agilent’s
Research Products Division. “If successful, these NMR strategies may
well revolutionize the field of cancer research.”
Dr. Mountford and her team are using Agilent’s
400-MR NMR Spectrometer, the 7510-AS
Autosampler, and NMR probes and software at a new state-of-the-art
NMR imaging center at Hunter
Medical Research Institute. The new facility features the most
advanced scanning technology in the Southern Hemisphere.
The Agilent Thought Leader Award promotes fundamental scientific
advances by contributing financial support, products and expertise to
the research of influential thought leaders in the life sciences and
chemical analysis space. Information about previous award recipients is
available at Agilent’s Thought
Leader Program website.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement
company and a technology leader in chemical analysis, life sciences,
diagnostics, electronics and communications. The company’s 20,600
employees serve customers in more than 100 countries. Agilent had
revenues of $6.8 billion in fiscal 2013. Information about Agilent is
available at www.agilent.com.
On Sept. 19, 2013, Agilent announced plans to separate into two publicly
traded companies through a tax-free spinoff of its electronic
measurement business. The new company is named Keysight Technologies,
Inc. The separation is expected to be completed in early November 2014.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available at www.agilent.com/go/news.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140522005091r1&sid=ntxv4&distro=nx)
Copyright Business Wire 2014